Close Menu
    Facebook X (Twitter) Instagram
    • Home
    • About Us
    • Digital Subscription
    • Advertisement
    • Contact Us
    X (Twitter) Instagram
    The Tennessee TribuneThe Tennessee Tribune
    Advertise With Us
    • Home
      • Featured
    • News
      • State
      • Local
      • National/International News
      • Global
      • Business
        • Commentary
        • Finance
        • Local Business
      • Investigative Stories
        • Affordable Housing
        • DCS Investigation
        • Gentrification
    • Editorial
      • National Politics
      • Local News
      • Local Editorial
      • Political Editorial
      • Editorial Cartoons
      • Cycle of Shame
    • Community
      • History
      • Tennessee
        • Chattanooga
        • Clarksville
        • Knoxville
        • Memphis
      • Public Notices
      • Women
        • Let’s Talk with Ms. June
    • Education
      • College
        • American Baptist College
        • Belmont University
        • Fisk
        • HBCU
        • Meharry
        • MTSU
        • University of Tennessee
        • TSU
        • Vanderbilt
      • Elementary
      • High School
    • Lifestyle
      • Art
      • Auto
      • Tribune Travel
      • Entertainment
        • 5 Questions With
        • Books
        • Events
        • Film Review
        • Local Entertainment
      • Family
      • Food
        • Drinks
      • Health & Wellness
      • Home & Garden
      • Featured Books
    • Religion
      • National Religion
      • Local Religion
      • Obituaries
        • National Obituaries
        • Local Obituaries
      • Faith Commentary
    • Sports
      • MLB
        • Sounds
      • NBA
      • NCAA
      • NFL
        • Predators
        • Titans
      • NHL
      • Other Sports
      • Golf
      • Professional Sports
      • Sports Commentary
      • Metro Sports
    • Media
      • Video
      • Photo Galleries
      • Take 10
      • Trending With The Tribune
    • Classified
    • Obituaries
      • Local Obituaries
      • National Obituaries
    The Tennessee TribuneThe Tennessee Tribune
    Politics

    Opinion: This Bill Delays Life-saving Treatments, Making it the Difference Between Life and Death

    Article submittedBy Article submittedApril 12, 2022Updated:April 12, 2022No Comments3 Mins Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit Email
    Guy Anthony is the president and CEO of Black, Gifted & Whole. He says as a Black man living with HIV he fears this legislation will have disastrous consequences for millions of Americans, especially the most vulnerable among us.
    Share
    Facebook Twitter LinkedIn Pinterest Email
    Advertisement

    By Guy Anthony

    Congressman Frank Pallone, Jr. recently introduced a bill that could delay patients’ access to lifesaving treatments — and even take FDA-approved medicines away from patients who are already using them. As a Black man living with HIV and a lifelong advocate for patients, I fear this legislation will have disastrous consequences for millions of Americans, especially the most vulnerable among us.

    The bill essentially neuters the FDA’s “accelerated approval” pathway, which regulators established at the height of the HIV/AIDs epidemic. In the late 1980s and early 1990s, thousands of Americans were dying from this disease each year. Patient groups pleaded with the FDA to expedite the approval of promising treatments.

    Regulators listened — and in 1992 created a pathway to expeditiously assess the efficacy of treatments for serious and life-threatening conditions like HIV. Rather than measuring “clinical benefit” — an increase in long-term survival rates, for instance — the FDA began assessing HIV medications based on “surrogate endpoints” — markers that are likely to predict clinical benefit, such as higher t-cell counts that enable the immune system to suppress the virus.

    The pathway gave patients faster access to medicines that saved their lives. Had the drugs gone through the traditional approval process, it would have taken additional years to definitively prove they extended life expectancies.

    Drugmakers still have to conduct confirmatory trials to ensure the medications ultimately provide the anticipated clinical benefit. Only after these trials are complete can drugs receive traditional FDA approval.

    The accelerated approval pathway has extended and saved thousands of HIV patients’ lives. Between 1992 and 2010, roughly 40% of the drugs approved through the accelerated pathway treated HIV. The FDA later granted all of them traditional approval.

    I can’t help but think how my story could have been different, had I not had immediate access to some of these treatment options when I was diagnosed with HIV. I wasn’t even 20 years old. But thanks to cutting-edge drugs, I’ve lived a fairly normal life for the past 17 years.

    All told, more than 260 drugs treating conditions ranging from HIV to cancer to rare diseases have gotten to patients quicker thanks to the accelerated approval pathway.

    They also offer greater health gains than medications approved through the traditional FDA pathway, according to research in Health Affairs.

    Despite the success of accelerated approval, Congressman Pallone have taken aim at the pathway. His bill could pull medicines off the market if post-accelerated-approval studies haven’t been completed within five years. It could subject drugmakers to criminal penalties if they don’t conduct confirmatory trials with “due diligence” — in other words, on a vaguely defined timetable set by bureaucrats. And it could deter patients from weighing in on a medication before the FDA withdraws its approval.

    These draconian measures could discourage drugmakers from applying for accelerated approval. After all, why would a manufacturer make efforts to recruit and retain patients in complex, expensive clinical trials just for the FDA to pull its drug from the market?

    Minority patients will suffer disproportionately from such decisions. That’s because Americans of color bear the outsized burden of the life-threatening illnesses typically targeted by drugs given accelerated approval.

    For these Americans and countless others, drugs given accelerated approval often mean the difference between life and death. Preserving this critical pathway will help ensure future patients have a chance at life — just as I had.

    Guy Anthony is the president and CEO of Black, Gifted & Whole. This piece originally ran in the New Jersey Star-Ledger.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Article submitted

    Related Posts

    California Legislative Black Caucus Grows to 14, Women Hold 12 Seats

    November 18, 2026

    Tennessee Black Caucus Elects Rep. Ronnie Glynn of Clarksville New Chairman

    November 17, 2026

    Keisha Lance Bottoms to Govern State Where Her Great-Great-Grandfather Was Enslaved

    November 16, 2026

    The Magnitude Of The Midterm Elections Showed The Power Of The People

    November 10, 2026

    ‘You Can’t Rig a Movement’: Pearson Answers Questions from MLK50 After Historic Race

    November 10, 2026

    Tennessee Democrats Flip Eight Counties from Red to Blue

    November 9, 2026

    Comments are closed.

    Business

    Lyft and Waymo Prepare for Major Nashville Expansion

    November 18, 2026

    Nashville Hosts Historic Ghana-Tennessee Business Roundtable as Part of Four-Day Trade Mission

    November 17, 2026

    Sports Illustrated Resorts Opens in Nashville

    November 17, 2026
    1 2 3 … 413 Next
    Education
    Vanderbilt

    Vanderbilt Kennedy Center Awarded $19.6 Million in Tennessee Department of Education Contracts

    By VanderbiltNovember 18, 2026

    By: Danny Bonvissuto Vanderbilt Kennedy Center has been awarded three new contracts from the Tennessee…

    Vanderbilt University Investigates Cybersecurity Attack, Ransomware Group Claims Data Breach

    November 18, 2026

    LG Opens ‘Life’s Good Lounge’ at Vanderbilt University

    November 17, 2026

    Meharry Expands Women’s Health Services to Two Nashville Locations

    November 16, 2026
    The Tennessee Tribune
    X (Twitter) Instagram
    • About Us
    • Digital Subscription
    • Store
    • Advertise With Us
    • Contact
    © 2026 The Tennessee Tribune - Site Designed by No Regret Media.

    Type above and press Enter to search. Press Esc to cancel.